tiprankstipranks
Trending News
More News >

Crinetics treatment of carcinoid syndrome granted FDA orphan status

Crinetics (CRNX)’ paltusotine was granted FDA orphan designation status as a treatment of carcinoid syndrome, according to a post to the agency’s website.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue